Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Oct 16, 2025; 17(10): 109031
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.109031
Published online Oct 16, 2025. doi: 10.4253/wjge.v17.i10.109031
Table 1 Endoscopic bariatric techniques
Techniques | |
Gastric resection | Space occupying devices |
Intragastric balloons | |
Transpyloric shuttle | |
SatiSphere | |
Gelesis100 | |
Stapling devices | |
Apollo OverStitch | |
Primary obesity surgery endolumenal | |
Endomnia | |
Articulating circular endoscopic devise | |
Malabsorption | Endobarrier |
Gastroduodenojejunal bypass sleeve | |
SatiSphere | |
REVITA DMR system | |
Incision-less anastomosis system | |
Other mechanisms | Aspire assist |
Botulinum toxin injection |
Table 2 Intragastric balloon characteristics
Balloon type | Orbera | ReShape Duo1 | Obalon | Heliosphere | Spatz2 | Elipse |
Manufacturer | Apollo Endosurgery | ReShape Medical | Obalon Therapeutics | Helioscopie Medical Implants | Spatz FGIA | Allurion Technologies |
Filled with | Saline | Saline | Nitrogen gas | Air | Saline | Liquid |
Capacity (mL) adjustable | 400-700 | 450 × 2 | 250 × 3 | 900-1000 | 300-900 | 550 |
Number of balloons | 1 | 2 | Up to 3 | 1 | 1 | 1 |
Insertion | Endoscopy | Endoscopy | Swallowed | Endoscopy | Endoscopy | Endoscopy |
Removal | Endoscopy | |||||
Duration | 6 | 6 | 6 | 6 | 12 | 6 |
Adjustable | No | No | No | No | Yes | No |
Table 3 Adverse events, %
Adverse event | ReShape Duo | Orbera | Obalon |
Vomiting | 86.7 | 86.8 | 17.3 |
Nausea | 61.0 | 75.6 | 56.0 |
Abdominal pain | 54.5 | 57.5 | 72.6 |
Gastric ulcer | 35.2 | 0.0 | 0.9 |
Dyspepsia | 17.8 | 21.3 | 16.9 |
Table 4 Estimated weight loss
Endoscopic bariatric techniques | |
Fluid-filled intragastric balloons | |
Orbera/BIB | 34%-42% EWL at 6 months |
Silimed gastric balloon | 8 kg after 6 months |
MedSil intragastric balloon | 19% EWL at 6 months |
Spatz adjustable balloon system | 46% EWL at 12 months |
ReShape dual intragastric balloon system | 25% EWL at 6 months |
Air/gas-filled intragastric balloons | |
Heliosphere BAG balloon | 18% EWL at 6 months |
Obalon gastric balloon | 5 kg after 12 weeks |
Ullorex oral intragastric balloon | 1.5 kg over 2 weeks |
Other space-occupying devices | |
SAB | 6.5 kg after 4 months |
TPS | 25% EWL at 3 months 41% EWL at 6 months |
SatiSphere | 18.4 kg after 3 months |
Gelesis100 | 29% EWL after 24 weeks |
Suturing/stapling procedures | |
EndoCinch suturing system | 40% EWL at 3 months 58% EWL at 12 months |
Restore suturing system | 28% EWL at 12 months |
Overstitch endoscopic suturing system | 30% EWL at 6 months 55% EWL at 12 months |
TOGA | 25%-46% EWL at 6 months 39% EWL at 12 months |
TERIS | 30% EWL at 6 months POSE 45% EWL at 12 months |
Endomina suturing system | 29% EWL at 12 months |
Malabsorptive endoscopic weight loss procedures DJBS | 12-24% EWL at 3 months 32% EWL at 6 months |
Gastroduodenal-DJBS months 54% EWL | 40% EWL at 3 at 12 months |
Other endoscopic weight loss procedures | |
DMR | 2.5 kg after 24 weeks Incisionless magnetic anastomosis system 40% EWL at 12 months |
Intragastric injections of botulinum toxin A | 11 kg after 2 months V-BLOC 17% EWL at 12 months |
GES | 5 kg after 6 months Gastric aspiration therapy/AspireAssist 41% EWL at 6 months 50% EWL at 12 months |
- Citation: Moutzoukis MK, Argyriou K, Manolakis A, Kapsoritakis A, Christodoulou D. Endoscopic bariatrics: Current status and emerging technologies. World J Gastrointest Endosc 2025; 17(10): 109031
- URL: https://www.wjgnet.com/1948-5190/full/v17/i10/109031.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i10.109031